Fuji Pharma (4554) · RiskFirst stated

Credit Risk on Trade Receivables and Mitigation Through Security Deposits

First written in FY2019. . Latest entry: FY2019.

1entries

1years

0from disclosures

Share on X

How it moved

Same theme, other companies

Managing Counterparty Credit RiskA theme 903 companies write about · 923 as a headwind · 18 as a tailwind

The whole theme swung hardest in 2026: 19 of 65 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 194 companies compared. The sentences above are computed from all 194.Comparing 200 of the theme's 942 threads.

Full recordFilings, disclosures and news, newest first

FY2019First statedAnnual report
「Notes and accounts receivable, which are trade receivables, are exposed to the credit risk of customers. To mitigate this risk, we manage payment due dates and outstanding balances for each customer in accordance with our internal rules and, after taking the customer's credit status into account, seek to reduce the risk by receiving security deposits from customers.」
The Company has disclosed for the first time the credit risk of customers relating to notes and accounts receivable, along with mitigation measures involving due-date and balance management and security deposits.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for Fuji Pharma yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.